294 related articles for article (PubMed ID: 36411768)
21. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.
Stoelinga AEC; Tushuizen ME; van den Hout WB; Girondo MDMR; de Vries ES; Levens AD; Moes DAR; Gevers TJG; van der Meer S; Brouwer HT; de Jonge HJM; de Boer YS; Beuers UHW; van der Meer AJ; van den Berg AP; Guichelaar MMJ; Drenth JPH; van Hoek B;
Trials; 2024 Jan; 25(1):61. PubMed ID: 38233878
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.
Wolf DC; Bojito L; Facciuto M; Lebovics E
Dig Dis Sci; 2009 Nov; 54(11):2519-22. PubMed ID: 19082888
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study.
Sukanjanapong S; Thongtan D; Kanokrungsee S; Suchonwanit P; Chanprapaph K
Dermatol Ther (Heidelb); 2020 Feb; 10(1):179-189. PubMed ID: 31865535
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Ma J; Yu H; Wang H; Zhang X; Feng K
J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
[TBL] [Abstract][Full Text] [Related]
26. [Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment].
Miura R; Yagi M; Matsumoto K; Miki A; Isono A; Aoyagi H; Abe K; Tachizawa N; Arizumi T; Aiso M; Kodashima S; Asaoka Y; Yamamoto T; Tanaka A
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(4):318-326. PubMed ID: 33840713
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
[TBL] [Abstract][Full Text] [Related]
29. Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
Argolini LM; Frontini G; Elefante E; Saccon F; Binda V; Tani C; Scotti I; Carli L; Gatto M; Esposito C; Gerosa M; Caporali R; Doria A; Messa P; Mosca M; Moroni G
J Nephrol; 2021 Apr; 34(2):389-398. PubMed ID: 32462476
[TBL] [Abstract][Full Text] [Related]
30. The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study.
Yüksekyayla O; Kina N; Ulaba A; Emin Ergün M; Batibay E; Şimşek C; Yildiz Zeyrek F; Wahlin S; Efe C
Eur J Gastroenterol Hepatol; 2024 May; 36(5):652-656. PubMed ID: 38477840
[TBL] [Abstract][Full Text] [Related]
31. Advancements in autoimmune hepatitis management: Perspectives for future guidelines.
Mucenic M
World J Hepatol; 2024 Feb; 16(2):135-139. PubMed ID: 38495280
[TBL] [Abstract][Full Text] [Related]
32. Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
Zachou K; Weiler-Normann C; Muratori L; Muratori P; Lohse AW; Dalekos GN
Liver Int; 2020 Feb; 40(2):368-376. PubMed ID: 31626725
[TBL] [Abstract][Full Text] [Related]
33. Features and outcome of AIH patients without elevation of IgG.
Hartl J; Miquel R; Zachou K; Wong GW; Asghar A; Pape S; Sebode M; Peiseler M; Zenouzi R; Ehlken H; Krech T; Weiler-Normann C; Drenth JPH; Oo YH; Dalekos GN; Heneghan M; Schramm C; Lohse AW
JHEP Rep; 2020 Jun; 2(3):100094. PubMed ID: 32280942
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
[TBL] [Abstract][Full Text] [Related]
35. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Mathew TH
Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801
[TBL] [Abstract][Full Text] [Related]
36. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
Triemer HL; Pearson TC; Odom KL; Larsen CP
Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
[TBL] [Abstract][Full Text] [Related]
37. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
[TBL] [Abstract][Full Text] [Related]
39. Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.
Zuckermann A; Klepetko W; Birsan T; Taghavi S; Artemiou O; Wisser W; Dekan G; Wolner E
J Heart Lung Transplant; 1999 May; 18(5):432-40. PubMed ID: 10363687
[TBL] [Abstract][Full Text] [Related]
40. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
